A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab (BMS-936558, anti-PD-1 Monoclonal Antibody) in Advanced Cancers

Project: Research

Project Description

NMA Reference Number: HREC/16/MH/14
SSA Reference Number: SSA/16/MonH/373
Monash Health HREC Ref: RES-16-0000557X
StatusActive
Effective start/end date29/01/1928/01/24